Treatment of rheumatoid arthritis (RA)-related interstitial lung disease (ILD) is challenging, and many conventional and biologic disease-modifying anti-rheumatic drugs (DMARDs) have been associated with ILD development or progression. The aim of this multicentric retrospective study was to analyze the evolution of ILD in Italian RA-ILD patients treated with abatacept (ABA).
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study / Cassone, Giulia; Manfredi, Andreina; Atzeni, Fabiola; Venerito, Vincenzo; Vacchi, Caterina; Picerno, Valentina; Furini, Federica; Erre, Gian Luca; Tomietto, Paola; Fedele, Anna Laura; Della Casa, Giovanni; Nucera, Valeria; Giannitti, Chiara; Salvarani, Carlo; Sebastiani, Marco. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 9:1(2020), p. 277. [10.3390/jcm9010277]